{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:09:53Z","timestamp":1783523393953,"version":"3.55.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09839-1","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T11:03:25Z","timestamp":1723115005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adenosine A2AR in viral immune evasion and therapy: unveiling new avenues for treating COVID-19 and AIDS"],"prefix":"10.1007","volume":"51","author":[{"given":"Muhammad","family":"Atif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alsrhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrah","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abualgasim Elgaili","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ikram","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi Bi Zainab","family":"Mazhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lienda Bashier","family":"Eltayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"issue":"1","key":"9839_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s43094-021-00353-w","volume":"7","author":"R Batra","year":"2021","unstructured":"Batra R, Jain V, Sharma P (2021) Adenosine: a partially discovered medicinal agent. Futur J Pharm Sci 7(1):214. https:\/\/doi.org\/10.1186\/s43094-021-00353-w","journal-title":"Futur J Pharm Sci"},{"issue":"2","key":"9839_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/cell.2020.0087","volume":"23","author":"M Atif","year":"2021","unstructured":"Atif M, Alsrhani A, Naz F, Imran M, Imran M, Ullah MI et al (2021) Targeting Adenosine receptors in Neurological diseases. Cell Reprogram 23(2):57\u201372. https:\/\/doi.org\/10.1089\/cell.2020.0087","journal-title":"Cell Reprogram"},{"issue":"5","key":"9839_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18(5):1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"key":"9839_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9717-6_1","volume":"2041","author":"G Burnstock","year":"2020","unstructured":"Burnstock G (2020) Introduction to Purinergic Signaling. Methods Mol Biol 2041:1\u201315. https:\/\/doi.org\/10.1007\/978-1-4939-9717-6_1","journal-title":"Methods Mol Biol"},{"issue":"3","key":"9839_CR5","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"9839_CR6","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/s0735-1097(85)80027-9","volume":"5","author":"S Favale","year":"1985","unstructured":"Favale S, Di Biase M, Rizzo U, Belardinelli L, Rizzon P (1985) Effect of adenosine and adenosine-5\u2019-triphosphate on atrioventricular conduction in patients. J Am Coll Cardiol 5(5):1212\u20131219. https:\/\/doi.org\/10.1016\/s0735-1097(85)80027-9","journal-title":"J Am Coll Cardiol"},{"issue":"6866","key":"9839_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","volume":"414","author":"A Ohta","year":"2001","unstructured":"Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414(6866):916\u2013920. https:\/\/doi.org\/10.1038\/414916a","journal-title":"Nature"},{"issue":"4","key":"9839_CR8","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1073\/pnas.052706699","volume":"99","author":"H Kojima","year":"2002","unstructured":"Kojima H, Gu H, Nomura S, Caldwell CC, Kobata T, Carmeliet P et al (2002) Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha -deficient chimeric mice. Proc Natl Acad Sci U S A 99(4):2170\u20132174. https:\/\/doi.org\/10.1073\/pnas.052706699","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"35","key":"9839_CR9","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK et al (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 103(35):13132\u201313137. https:\/\/doi.org\/10.1073\/pnas.0605251103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9839_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K (2018) Pharmacology of Adenosine receptors: the state of the art. Physiol Rev 98(3):1591\u20131625. https:\/\/doi.org\/10.1152\/physrev.00049.2017","journal-title":"Physiol Rev"},{"issue":"1","key":"9839_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L (2023) CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer 22(1):44. https:\/\/doi.org\/10.1186\/s12943-023-01733-x","journal-title":"Mol Cancer"},{"issue":"12","key":"9839_CR12","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1158\/2159-8290.CD-19-0541","volume":"9","author":"XY Li","year":"2019","unstructured":"Li XY, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H et al (2019) Targeting CD39 in Cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity. Cancer Discov 9(12):1754\u20131773. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0541","journal-title":"Cancer Discov"},{"issue":"1","key":"9839_CR13","doi-asserted-by":"publisher","first-page":"e000610","DOI":"10.1136\/jitc-2020-000610","volume":"8","author":"R Yang","year":"2020","unstructured":"Yang R, Elsaadi S, Misund K, Abdollahi P, Vandsemb EN, Moen SH et al (2020) Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. J Immunother Cancer 8(1):e000610. https:\/\/doi.org\/10.1136\/jitc-2020-000610","journal-title":"J Immunother Cancer"},{"issue":"8","key":"9839_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1021\/acsmedchemlett.7b00255","volume":"8","author":"AF Abdel-Magid","year":"2017","unstructured":"Abdel-Magid AF (2017) Inhibitors of CD73 may provide a treatment for Cancer and Autoimmune diseases. ACS Med Chem Lett 8(8):781\u2013782. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00255","journal-title":"ACS Med Chem Lett"},{"key":"9839_CR15","doi-asserted-by":"publisher","first-page":"1012027","DOI":"10.3389\/fimmu.2022.1012027","volume":"13","author":"AJ Pietrobon","year":"2022","unstructured":"Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira LM, Scholl JN, Teixeira FME et al (2022) Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Front Immunol 13:1012027. https:\/\/doi.org\/10.3389\/fimmu.2022.1012027","journal-title":"Front Immunol"},{"issue":"6","key":"9839_CR16","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.celrep.2013.05.022","volume":"3","author":"F Schena","year":"2013","unstructured":"Schena F, Volpi S, Faliti CE, Penco F, Santi S, Proietti M et al (2013) Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. Cell Rep 3(6):1824\u20131831. https:\/\/doi.org\/10.1016\/j.celrep.2013.05.022","journal-title":"Cell Rep"},{"key":"9839_CR17","doi-asserted-by":"publisher","first-page":"613070","DOI":"10.3389\/fimmu.2021.613070","volume":"12","author":"M Caracciolo","year":"2021","unstructured":"Caracciolo M, Correale P, Mangano C, Foti G, Falcone C, Macheda S et al (2021) Efficacy and effect of inhaled Adenosine Treatment in Hospitalized COVID-19 patients. Front Immunol 12:613070. https:\/\/doi.org\/10.3389\/fimmu.2021.613070","journal-title":"Front Immunol"},{"key":"9839_CR18","doi-asserted-by":"publisher","first-page":"100071","DOI":"10.1016\/j.bbih.2020.100071","volume":"5","author":"M Kawano","year":"2020","unstructured":"Kawano M, Saika K, Takagi R, Matsui M, Matsushita S (2020) Tannic acid acts as an agonist of the dopamine D2L receptor, regulates immune responses, and ameliorates experimentally induced colitis in mice. Brain Behav Immun Health 5:100071. https:\/\/doi.org\/10.1016\/j.bbih.2020.100071","journal-title":"Brain Behav Immun Health"},{"issue":"4","key":"9839_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/25785826.2022.2094593","volume":"45","author":"M Tokano","year":"2022","unstructured":"Tokano M, Kawano M, Takagi R, Matsushita S (2022) Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4(+) T-cell hypersecretion of IL-17A and IL-8 in humans. Immunol Med 45(4):244\u2013250. https:\/\/doi.org\/10.1080\/25785826.2022.2094593","journal-title":"Immunol Med"},{"key":"9839_CR20","doi-asserted-by":"publisher","first-page":"100544","DOI":"10.1016\/j.bbih.2022.100544","volume":"26","author":"M Tokano","year":"2022","unstructured":"Tokano M, Matsushita S, Takagi R, Yamamoto T, Kawano M (2022) Extracellular adenosine induces hypersecretion of IL-17A by T-helper 17 cells through the adenosine A2a receptor. Brain Behav Immun Health 26:100544. https:\/\/doi.org\/10.1016\/j.bbih.2022.100544","journal-title":"Brain Behav Immun Health"},{"issue":"4","key":"9839_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cen3.12472","volume":"9","author":"T Matsuyama","year":"2018","unstructured":"Matsuyama T, Kawano M, Takagi R, Nakagome K, Chikamatsu K, Matsushita S (2018) Interleukin-8 produced by T cells is under the control of dopamine signaling. Clin Exp Immunol 9(4):251\u2013257. https:\/\/doi.org\/10.1111\/cen3.12472","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"9839_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","volume":"86","author":"B Friedman","year":"2019","unstructured":"Friedman B, Cronstein B (2019) Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine 86(3):301\u2013307. https:\/\/doi.org\/10.1016\/j.jbspin.2018.07.004","journal-title":"Joint Bone Spine"},{"issue":"8","key":"9839_CR23","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1111\/cas.14091","volume":"110","author":"J Long","year":"2019","unstructured":"Long J, Hu Z, Xue H, Wang Y, Chen J, Tang F et al (2019) Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway. Cancer Sci 110(8):2357\u20132367. https:\/\/doi.org\/10.1111\/cas.14091","journal-title":"Cancer Sci"},{"issue":"1","key":"9839_CR24","doi-asserted-by":"publisher","first-page":"e0191040","DOI":"10.1371\/journal.pone.0191040","volume":"13","author":"KC Wheeler","year":"2018","unstructured":"Wheeler KC, Jena MK, Pradhan BS, Nayak N, Das S, Hsu CD et al (2018) VEGF may contribute to macrophage recruitment and M2 polarization in the decidua. PLoS ONE 13(1):e0191040. https:\/\/doi.org\/10.1371\/journal.pone.0191040","journal-title":"PLoS ONE"},{"issue":"Pt B","key":"9839_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pnpbp.2017.06.034","volume":"79","author":"SF Ahmad","year":"2017","unstructured":"Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Attia SM (2017) Toll-like receptors, NF-kappaB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T(+) Itpr3(tf)\/J mice. Prog Neuropsychopharmacol Biol Psychiatry 79(Pt B):184\u2013191. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.034","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"9839_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.molimm.2014.10.012","volume":"63","author":"C Liu","year":"2015","unstructured":"Liu C, Shang Q, Bai Y, Guo C, Zhu F, Zhang L et al (2015) Adenosine A2A receptor, a potential valuable target for controlling reoxygenated DCs-triggered inflammation. Mol Immunol 63(2):559\u2013565. https:\/\/doi.org\/10.1016\/j.molimm.2014.10.012","journal-title":"Mol Immunol"},{"key":"9839_CR27","doi-asserted-by":"publisher","unstructured":"Borodovsky A, Barbon CM, Wang Y, Ye M, Prickett L, Chandra D et al (2020) Small molecule AZD4635 inhibitor of A(2A)R signaling rescues immune cell function including CD103(+) dendritic cells enhancing anti-tumor immunity. J Immunother Cancer 8(2). https:\/\/doi.org\/10.1136\/jitc-2019-000417","DOI":"10.1136\/jitc-2019-000417"},{"issue":"9","key":"9839_CR28","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1681\/ASN.2012010070","volume":"23","author":"GR Kinsey","year":"2012","unstructured":"Kinsey GR, Huang L, Jaworska K, Khutsishvili K, Becker DA, Ye H et al (2012) Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol 23(9):1528\u20131537. https:\/\/doi.org\/10.1681\/ASN.2012010070","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"9839_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0006-2952(02)01548-4","volume":"65","author":"MV Sitkovsky","year":"2003","unstructured":"Sitkovsky MV (2003) Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 65(4):493\u2013501. https:\/\/doi.org\/10.1016\/s0006-2952(02)01548-4","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"9839_CR30","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1084\/jem.20130249","volume":"210","author":"C Cekic","year":"2013","unstructured":"Cekic C, Sag D, Day YJ, Linden J (2013) Extracellular adenosine regulates naive T cell development and peripheral maintenance. J Exp Med 210(12):2693\u20132706. https:\/\/doi.org\/10.1084\/jem.20130249","journal-title":"J Exp Med"},{"issue":"4","key":"9839_CR31","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1074\/jbc.C116.764043","volume":"292","author":"RK Abbott","year":"2017","unstructured":"Abbott RK, Silva M, Labuda J, Thayer M, Cain DW, Philbrook P et al (2017) The GS protein-coupled A2a Adenosine Receptor Controls T Cell Help in the Germinal Center. J Biol Chem 292(4):1211\u20131217. https:\/\/doi.org\/10.1074\/jbc.C116.764043","journal-title":"J Biol Chem"},{"key":"9839_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.22.012703.104731","volume":"22","author":"MV Sitkovsky","year":"2004","unstructured":"Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C et al (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22:657\u2013682. https:\/\/doi.org\/10.1146\/annurev.immunol.22.012703.104731","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"9839_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46(6):1089\u20131098. https:\/\/doi.org\/10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"issue":"3","key":"9839_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jiph.2016.04.002","volume":"9","author":"R Taylor","year":"2016","unstructured":"Taylor R, Kotian P, Warren T, Panchal R, Bavari S, Julander J et al (2016) BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease. J Infect Public Health 9(3):220\u2013226. https:\/\/doi.org\/10.1016\/j.jiph.2016.04.002","journal-title":"J Infect Public Health"},{"issue":"3","key":"9839_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11302-015-9452-9","volume":"11","author":"G Burnstock","year":"2015","unstructured":"Burnstock G, Dale N (2015) Purinergic signalling during development and ageing. Purinergic Signal 11(3):277\u2013305. https:\/\/doi.org\/10.1007\/s11302-015-9452-9","journal-title":"Purinergic Signal"},{"issue":"10235","key":"9839_CR36","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","volume":"395","author":"H Li","year":"2020","unstructured":"Li H, Liu L, Zhang D, Xu J, Dai H, Tang N et al (2020) SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet 395(10235):1517\u20131520. https:\/\/doi.org\/10.1016\/S0140-6736(20)30920-X","journal-title":"Lancet"},{"issue":"21","key":"9839_CR37","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1111\/bph.15138","volume":"177","author":"F Di Virgilio","year":"2020","unstructured":"Di Virgilio F, Tang Y, Sarti AC, Rossato M (2020) A rationale for targeting the P2X7 receptor in Coronavirus disease 19. Br J Pharmacol 177(21):4990\u20134994. https:\/\/doi.org\/10.1111\/bph.15138","journal-title":"Br J Pharmacol"},{"key":"9839_CR38","doi-asserted-by":"publisher","first-page":"8632048","DOI":"10.1155\/2020\/8632048","volume":"2020","author":"F Dos Anjos","year":"2020","unstructured":"Dos Anjos F, Simoes JLB, Assmann CE, Carvalho FB, Bagatini MD (2020) Potential therapeutic role of Purinergic receptors in Cardiovascular Disease mediated by SARS-CoV-2. J Immunol Res 2020:8632048. https:\/\/doi.org\/10.1155\/2020\/8632048","journal-title":"J Immunol Res"},{"key":"9839_CR39","doi-asserted-by":"publisher","first-page":"110051","DOI":"10.1016\/j.mehy.2020.110051","volume":"143","author":"JJ DiNicolantonio","year":"2020","unstructured":"DiNicolantonio JJ, Barroso-Aranda J (2020) Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: potential of pentoxifylline and dipyridamole. Med Hypotheses 143:110051. https:\/\/doi.org\/10.1016\/j.mehy.2020.110051","journal-title":"Med Hypotheses"},{"key":"9839_CR40","doi-asserted-by":"publisher","unstructured":"Feret W, Nalewajska M, Wojczynski L, Witkiewicz W, Klos P, Dziedziejko V et al (2021) Pentoxifylline as a potential adjuvant therapy for COVID-19: impeding the Burden of the Cytokine Storm. J Clin Med 10(22). https:\/\/doi.org\/10.3390\/jcm10225305","DOI":"10.3390\/jcm10225305"},{"issue":"1","key":"9839_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/SHK.0b013e3181cdc3e2","volume":"34","author":"S Kreth","year":"2010","unstructured":"Kreth S, Ledderose C, Luchting B, Weis F, Thiel M (2010) Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways. Shock 34(1):10\u201316. https:\/\/doi.org\/10.1097\/SHK.0b013e3181cdc3e2","journal-title":"Shock"},{"key":"9839_CR42","doi-asserted-by":"publisher","unstructured":"Effendi WI, Nagano T, Kobayashi K, Nishimura Y (2020) Focusing on Adenosine Receptors as a potential targeted therapy in Human diseases. Cells 9(3). https:\/\/doi.org\/10.3390\/cells9030785","DOI":"10.3390\/cells9030785"},{"issue":"7","key":"9839_CR43","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","volume":"34","author":"MZ Ratajczak","year":"2020","unstructured":"Ratajczak MZ, Kucia M (2020) SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine storm and risk factor for damage of hematopoietic stem cells. Leukemia 34(7):1726\u20131729. https:\/\/doi.org\/10.1038\/s41375-020-0887-9","journal-title":"Leukemia"},{"key":"9839_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.phrs.2014.05.008","volume":"87","author":"P Balakumar","year":"2014","unstructured":"Balakumar P, Nyo YH, Renushia R, Raaginey D, Oh AN, Varatharajan R et al (2014) Classical and pleiotropic actions of dipyridamole: not enough light to illuminate the dark tunnel? Pharmacol Res 87:144\u2013150. https:\/\/doi.org\/10.1016\/j.phrs.2014.05.008","journal-title":"Pharmacol Res"},{"issue":"9","key":"9839_CR45","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1096\/fj.13-228122","volume":"27","author":"FM Konrad","year":"2013","unstructured":"Konrad FM, Neudeck G, Vollmer I, Ngamsri KC, Thiel M, Reutershan J (2013) Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent. FASEB J 27(9):3524\u20133535. https:\/\/doi.org\/10.1096\/fj.13-228122","journal-title":"FASEB J"},{"issue":"5","key":"9839_CR46","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/ndt\/gfh127","volume":"19","author":"YM Chen","year":"2004","unstructured":"Chen YM, Ng YY, Lin SL, Chiang WC, Lan HY, Tsai TJ (2004) Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats. Nephrol Dial Transpl 19(5):1106\u20131115. https:\/\/doi.org\/10.1093\/ndt\/gfh127","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"9839_CR47","first-page":"SR29","volume":"9","author":"JF Bermejo Martin","year":"2003","unstructured":"Bermejo Martin JF, Jimenez JL, Munoz-Fernandez A (2003) Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered. Med Sci Monit 9(6):SR29\u201334","journal-title":"Med Sci Monit"},{"issue":"7","key":"9839_CR48","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.apsb.2020.04.008","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu X, Li Z, Liu S, Sun J, Chen Z, Jiang M et al (2020) Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm Sin B 10(7):1205\u20131215. https:\/\/doi.org\/10.1016\/j.apsb.2020.04.008","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"9839_CR49","doi-asserted-by":"publisher","first-page":"e000365","DOI":"10.1136\/openhrt-2015-000365","volume":"3","author":"MF McCarty","year":"2016","unstructured":"McCarty MF, O\u2019Keefe JH, DiNicolantonio JJ (2016) Pentoxifylline for vascular health: a brief review of the literature. Open Heart 3(1):e000365. https:\/\/doi.org\/10.1136\/openhrt-2015-000365","journal-title":"Open Heart"},{"issue":"8","key":"9839_CR50","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.4049\/jimmunol.169.8.4262","volume":"169","author":"R Suresh","year":"2002","unstructured":"Suresh R, Vig M, Bhatia S, Goodspeed EP, John B, Kandpal U et al (2002) Pentoxifylline functions as an adjuvant in vivo to enhance T cell immune responses by inhibiting activation-induced death. J Immunol 169(8):4262\u20134272. https:\/\/doi.org\/10.4049\/jimmunol.169.8.4262","journal-title":"J Immunol"},{"issue":"8","key":"9839_CR51","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.26355\/eurrev_202004_21038","volume":"24","author":"SA Meo","year":"2020","unstructured":"Meo SA, Klonoff DC, Akram J (2020) Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci 24(8):4539\u20134547. https:\/\/doi.org\/10.26355\/eurrev_202004_21038","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"9839_CR52","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1371\/journal.pbio.0030174","volume":"3","author":"M Thiel","year":"2005","unstructured":"Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P et al (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 3(6):e174. https:\/\/doi.org\/10.1371\/journal.pbio.0030174","journal-title":"PLoS Biol"},{"issue":"8","key":"9839_CR53","doi-asserted-by":"publisher","first-page":"e19226","DOI":"10.1016\/j.heliyon.2023.e19226","volume":"9","author":"BJ Mann","year":"2023","unstructured":"Mann BJ, Chhabra P, Ma M, Brovero SG, Hannan RT, Sturek JM et al (2023) Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A(2A)R agonist. Heliyon 9(8):e19226. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19226","journal-title":"Heliyon"},{"issue":"8","key":"9839_CR54","doi-asserted-by":"publisher","first-page":"e0288920","DOI":"10.1371\/journal.pone.0288920","volume":"18","author":"J Rabin","year":"2023","unstructured":"Rabin J, Zhao Y, Mostafa E, Al-Suqi M, Fleischmann E, Conaway MR et al (2023) Regadenoson for the treatment of COVID-19: a five case clinical series and mouse studies. PLoS ONE 18(8):e0288920. https:\/\/doi.org\/10.1371\/journal.pone.0288920","journal-title":"PLoS ONE"},{"key":"9839_CR55","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fimmu.2019.00925","volume":"10","author":"S Vigano","year":"2019","unstructured":"Vigano S, Alatzoglou D, Irving M, Menetrier-Caux C, Caux C, Romero P et al (2019) Targeting Adenosine in Cancer Immunotherapy to enhance T-Cell function. Front Immunol 10:925. https:\/\/doi.org\/10.3389\/fimmu.2019.00925","journal-title":"Front Immunol"},{"issue":"3","key":"9839_CR56","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","volume":"3","author":"J Bastid","year":"2015","unstructured":"Bastid J, Regairaz A, Bonnefoy N, Dejou C, Giustiniani J, Laheurte C et al (2015) Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Cancer Immunol Res 3(3):254\u2013265. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0018","journal-title":"Cancer Immunol Res"},{"key":"9839_CR57","doi-asserted-by":"crossref","unstructured":"Siu LL, Burris H, Le DT, Hollebecque A, Steeghs N, Delord J-P et al (2018) Abstract CT180: preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors. Cancer Res p. CT180\u2013CT","DOI":"10.1158\/1538-7445.AM2018-CT180"},{"key":"9839_CR58","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1016\/j.mehy.2020.110012","volume":"144","author":"MA Abouelkhair","year":"2020","unstructured":"Abouelkhair MA (2020) Targeting adenosinergic pathway and adenosine A(2A) receptor signaling for the treatment of COVID-19: a hypothesis. Med Hypotheses 144:110012. https:\/\/doi.org\/10.1016\/j.mehy.2020.110012","journal-title":"Med Hypotheses"},{"issue":"10","key":"9839_CR59","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1158\/2326-6066.CIR-18-0056","volume":"6","author":"SB Willingham","year":"2018","unstructured":"Willingham SB, Ho PY, Hotson A, Hill C, Piccione EC, Hsieh J et al (2018) A2AR antagonism with CPI-444 induces antitumor responses and augments efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in preclinical models. Cancer Immunol Res 6(10):1136\u20131149. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0056","journal-title":"Cancer Immunol Res"},{"key":"9839_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.csbj.2015.03.008","volume":"13","author":"RD Leone","year":"2015","unstructured":"Leone RD, Lo YC, Powell JD (2015) A2aR antagonists: next generation checkpoint blockade for cancer immunotherapy. Comput Struct Biotechnol J 13:265\u2013272. https:\/\/doi.org\/10.1016\/j.csbj.2015.03.008","journal-title":"Comput Struct Biotechnol J"},{"key":"9839_CR61","doi-asserted-by":"publisher","unstructured":"Korb VG, Schultz IC, Beckenkamp LR, Wink MR (2023) A systematic review of the role of Purinergic Signalling Pathway in the treatment of COVID-19. Int J Mol Sci 24(9). https:\/\/doi.org\/10.3390\/ijms24097865","DOI":"10.3390\/ijms24097865"},{"issue":"2","key":"9839_CR62","doi-asserted-by":"publisher","first-page":"103299","DOI":"10.1016\/j.amjoto.2021.103299","volume":"43","author":"JJ Lee","year":"2022","unstructured":"Lee JJ, Peterson AM, Kallogjeri D, Jiramongkolchai P, Kukuljan S, Schneider JS et al (2022) Smell changes and efficacy of nasal theophylline (SCENT) irrigation: a randomized controlled trial for treatment of post-viral olfactory dysfunction. Am J Otolaryngol 43(2):103299. https:\/\/doi.org\/10.1016\/j.amjoto.2021.103299","journal-title":"Am J Otolaryngol"},{"issue":"7","key":"9839_CR63","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/crj.13363","volume":"15","author":"GC Wall","year":"2021","unstructured":"Wall GC, Smith HL, Trump MW, Mohr JD, DuMontier SP, Sabates BL et al (2021) Pentoxifylline or Theophylline use in hospitalized COVID-19 patients requiring oxygen support. Clin Respir J 15(7):843\u2013846. https:\/\/doi.org\/10.1111\/crj.13363","journal-title":"Clin Respir J"},{"issue":"12","key":"9839_CR64","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.7150\/ijbs.76058","volume":"18","author":"CS Wu","year":"2022","unstructured":"Wu CS, Chiang HM, Chen Y, Chen CY, Chen HF, Su WC et al (2022) Prospects of Coffee Leaf against SARS-CoV-2 infection. Int J Biol Sci 18(12):4677\u20134689. https:\/\/doi.org\/10.7150\/ijbs.76058","journal-title":"Int J Biol Sci"},{"issue":"1","key":"9839_CR65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1152\/physiol.00010.2021","volume":"37","author":"K Halpin-Veszeleiova","year":"2022","unstructured":"Halpin-Veszeleiova K, Hatfield SM (2022) Therapeutic targeting of Hypoxia-A2-Adenosinergic pathway in COVID-19 patients. Physiol (Bethesda) 37(1):46\u201352. https:\/\/doi.org\/10.1152\/physiol.00010.2021","journal-title":"Physiol (Bethesda)"},{"issue":"6917","key":"9839_CR66","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nature01326","volume":"420","author":"J Cohen","year":"2002","unstructured":"Cohen J (2002) The immunopathogenesis of sepsis. Nature 420(6917):885\u2013891. https:\/\/doi.org\/10.1038\/nature01326","journal-title":"Nature"},{"issue":"5","key":"9839_CR67","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.4049\/jimmunol.165.5.2643","volume":"165","author":"TA Moore","year":"2000","unstructured":"Moore TA, Moore BB, Newstead MW, Standiford TJ (2000) Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J Immunol 165(5):2643\u20132650. https:\/\/doi.org\/10.4049\/jimmunol.165.5.2643","journal-title":"J Immunol"},{"issue":"7","key":"9839_CR68","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1164\/ajrccm.164.7.2103011","volume":"164","author":"D D\u2019Ambrosio","year":"2001","unstructured":"D\u2019Ambrosio D, Mariani M, Panina-Bordignon P, Sinigaglia F (2001) Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med 164(7):1266\u20131275. https:\/\/doi.org\/10.1164\/ajrccm.164.7.2103011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"9839_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475\u2013481. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet Respir Med"},{"issue":"7","key":"9839_CR70","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al (2020) Risk factors Associated with Acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 180(7):934\u2013943. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"issue":"7","key":"9839_CR71","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2326-6066.CIR-14-0075","volume":"2","author":"MV Sitkovsky","year":"2014","unstructured":"Sitkovsky MV, Hatfield S, Abbott R, Belikoff B, Lukashev D, Ohta A (2014) Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists. Cancer Immunol Res 2(7):598\u2013605. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0075","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"9839_CR72","doi-asserted-by":"publisher","first-page":"L12","DOI":"10.1152\/ajplung.00304.2020","volume":"320","author":"D Hanidziar","year":"2021","unstructured":"Hanidziar D, Robson SC (2021) Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19. Am J Physiol Lung Cell Mol Physiol 320(1):L12\u2013L6. https:\/\/doi.org\/10.1152\/ajplung.00304.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"9839_CR73","doi-asserted-by":"publisher","first-page":"10677","DOI":"10.1007\/s11033-022-07685-7","volume":"49","author":"M Atif","year":"2022","unstructured":"Atif M, Alsrhani A, Naz F, Ullah MI, Alameen AAM, Imran M et al (2022) Adenosine A(2A) receptor as a potential target for improving cancer immunotherapy. Mol Biol Rep 49(11):10677\u201310687. https:\/\/doi.org\/10.1007\/s11033-022-07685-7","journal-title":"Mol Biol Rep"},{"key":"9839_CR74","doi-asserted-by":"publisher","first-page":"594487","DOI":"10.3389\/fphar.2020.594487","volume":"11","author":"JD Geiger","year":"2020","unstructured":"Geiger JD, Khan N, Murugan M, Boison D (2020) Possible role of Adenosine in COVID-19 Pathogenesis and Therapeutic opportunities. Front Pharmacol 11:594487. https:\/\/doi.org\/10.3389\/fphar.2020.594487","journal-title":"Front Pharmacol"},{"issue":"9","key":"9839_CR75","doi-asserted-by":"publisher","first-page":"e1001665","DOI":"10.1371\/journal.pbio.1001665","volume":"11","author":"T Eckle","year":"2013","unstructured":"Eckle T, Brodsky K, Bonney M, Packard T, Han J, Borchers CH et al (2013) HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium. PLoS Biol 11(9):e1001665. https:\/\/doi.org\/10.1371\/journal.pbio.1001665","journal-title":"PLoS Biol"},{"key":"9839_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00848-6","author":"X Yuan","year":"2023","unstructured":"Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK (2023) Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nat Rev Drug Discov. https:\/\/doi.org\/10.1038\/s41573-023-00848-6","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9839_CR77","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-018-03105-2","volume":"9","author":"M Koeppen","year":"2018","unstructured":"Koeppen M, Lee JW, Seo SW, Brodsky KS, Kreth S, Yang IV et al (2018) Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury. Nat Commun 9(1):816. https:\/\/doi.org\/10.1038\/s41467-018-03105-2","journal-title":"Nat Commun"},{"issue":"10","key":"9839_CR78","doi-asserted-by":"publisher","first-page":"e0239692","DOI":"10.1371\/journal.pone.0239692","volume":"15","author":"P Correale","year":"2020","unstructured":"Correale P, Caracciolo M, Bilotta F, Conte M, Cuzzola M, Falcone C et al (2020) Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia. PLoS ONE 15(10):e0239692. https:\/\/doi.org\/10.1371\/journal.pone.0239692","journal-title":"PLoS ONE"},{"key":"9839_CR79","doi-asserted-by":"publisher","unstructured":"Lindo J, Nogueira C, Soares R, Cunha N, Almeida MR, Rodrigues L et al (2024) Genetic polymorphisms of P2RX7 but not of ADORA2A are Associated with the severity of SARS-CoV-2 infection. Int J Mol Sci 25(11). https:\/\/doi.org\/10.3390\/ijms25116135","DOI":"10.3390\/ijms25116135"},{"issue":"9","key":"9839_CR80","doi-asserted-by":"publisher","first-page":"ofab396","DOI":"10.1093\/ofid\/ofab396","volume":"8","author":"EA Hixson","year":"2021","unstructured":"Hixson EA, Borker PV, Jackson EK, Macatangay BJ (2021) The Adenosine Pathway and Human Immunodeficiency Virus-Associated inflammation. Open Forum Infect Dis 8(9):ofab396. https:\/\/doi.org\/10.1093\/ofid\/ofab396","journal-title":"Open Forum Infect Dis"},{"key":"9839_CR81","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3389\/fimmu.2018.02415","volume":"9","author":"E Pan","year":"2018","unstructured":"Pan E, Feng F, Li P, Yang Q, Ma X, Wu C et al (2018) Immune Protection of SIV Challenge by PD-1 Blockade during Vaccination in Rhesus monkeys. Front Immunol 9:2415. https:\/\/doi.org\/10.3389\/fimmu.2018.02415","journal-title":"Front Immunol"},{"issue":"7","key":"9839_CR82","doi-asserted-by":"publisher","first-page":"e1005661","DOI":"10.1371\/journal.ppat.1005661","volume":"12","author":"M Hoffmann","year":"2016","unstructured":"Hoffmann M, Pantazis N, Martin GE, Hickling S, Hurst J, Meyerowitz J et al (2016) Exhaustion of activated CD8 T cells predicts Disease Progression in primary HIV-1 infection. PLoS Pathog 12(7):e1005661. https:\/\/doi.org\/10.1371\/journal.ppat.1005661","journal-title":"PLoS Pathog"},{"issue":"6","key":"9839_CR83","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.jaci.2017.08.021","volume":"141","author":"D Fenoglio","year":"2018","unstructured":"Fenoglio D, Dentone C, Signori A, Di Biagio A, Parodi A, Kalli F et al (2018) CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: a new possible pathogenic mechanism for HIV infection? J Allergy Clin Immunol 141(6):2220\u201333e4. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.021","journal-title":"J Allergy Clin Immunol"},{"key":"9839_CR84","doi-asserted-by":"publisher","first-page":"687296","DOI":"10.3389\/fimmu.2021.687296","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Huang HH, Tu B, Zhou MJ, Hu W, Fu YL et al (2021) Reversal of the CD8(+) T-Cell exhaustion Induced by Chronic HIV-1 infection through combined blockade of the Adenosine and PD-1 pathways. Front Immunol 12:687296. https:\/\/doi.org\/10.3389\/fimmu.2021.687296","journal-title":"Front Immunol"},{"issue":"21","key":"9839_CR85","doi-asserted-by":"publisher","first-page":"11422","DOI":"10.1128\/JVI.05608-11","volume":"85","author":"JM Shaw","year":"2011","unstructured":"Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB et al (2011) Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol 85(21):11422\u201311434. https:\/\/doi.org\/10.1128\/JVI.05608-11","journal-title":"J Virol"},{"issue":"1","key":"9839_CR86","doi-asserted-by":"publisher","first-page":"e15924","DOI":"10.1371\/journal.pone.0015924","volume":"6","author":"PW Hunt","year":"2011","unstructured":"Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B et al (2011) A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS ONE 6(1):e15924. https:\/\/doi.org\/10.1371\/journal.pone.0015924","journal-title":"PLoS ONE"},{"issue":"7","key":"9839_CR87","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol 10(7):490\u2013500. https:\/\/doi.org\/10.1038\/nri2785","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"9839_CR88","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.4049\/jimmunol.0901247","volume":"183","author":"A Ohta","year":"2009","unstructured":"Ohta A, Ohta A, Madasu M, Kini R, Subramanian M, Goel N et al (2009) A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J Immunol 183(9):5487\u20135493. https:\/\/doi.org\/10.4049\/jimmunol.0901247","journal-title":"J Immunol"},{"issue":"7","key":"9839_CR89","doi-asserted-by":"publisher","first-page":"e1002110","DOI":"10.1371\/journal.ppat.1002110","volume":"7","author":"M Nikolova","year":"2011","unstructured":"Nikolova M, Carriere M, Jenabian MA, Limou S, Younas M, Kok A et al (2011) CD39\/adenosine pathway is involved in AIDS progression. PLoS Pathog 7(7):e1002110. https:\/\/doi.org\/10.1371\/journal.ppat.1002110","journal-title":"PLoS Pathog"},{"issue":"4","key":"9839_CR90","doi-asserted-by":"publisher","first-page":"e1003319","DOI":"10.1371\/journal.ppat.1003319","volume":"9","author":"MA Jenabian","year":"2013","unstructured":"Jenabian MA, Seddiki N, Yatim A, Carriere M, Hulin A, Younas M et al (2013) Regulatory T cells negatively affect IL-2 production of effector T cells through CD39\/adenosine pathway in HIV infection. PLoS Pathog 9(4):e1003319. https:\/\/doi.org\/10.1371\/journal.ppat.1003319","journal-title":"PLoS Pathog"},{"issue":"5","key":"9839_CR91","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/sj.emboj.7601012","volume":"25","author":"A Murayama","year":"2006","unstructured":"Murayama A, Sakura K, Nakama M, Yasuzawa-Tanaka K, Fujita E, Tateishi Y et al (2006) A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J 25(5):1081\u20131092. https:\/\/doi.org\/10.1038\/sj.emboj.7601012","journal-title":"EMBO J"},{"issue":"6","key":"9839_CR92","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1158\/0008-5472.CAN-09-3109","volume":"70","author":"D Jin","year":"2010","unstructured":"Jin D, Fan J, Wang L, Thompson LF, Liu A, Daniel BJ et al (2010) CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 70(6):2245\u20132255. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3109","journal-title":"Cancer Res"},{"key":"9839_CR93","doi-asserted-by":"publisher","unstructured":"Rickles RJ, Pierce LT, Giordano TP 3rd, Tam WF, McMillin DW, Delmore J et al (2010) Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies. Blood 116(4):593\u2013602. https:\/\/doi.org\/10.1182\/blood-2009-11-252668","DOI":"10.1182\/blood-2009-11-252668"},{"issue":"12","key":"9839_CR94","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","volume":"20","author":"AK Moesta","year":"2020","unstructured":"Moesta AK, Li XY, Smyth MJ (2020) Targeting CD39 in cancer. Nat Rev Immunol 20(12):739\u2013755. https:\/\/doi.org\/10.1038\/s41577-020-0376-4","journal-title":"Nat Rev Immunol"},{"key":"9839_CR95","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3389\/fimmu.2019.02465","volume":"10","author":"JW Song","year":"2019","unstructured":"Song JW, Huang HH, Zhang C, Yang HG, Zhang JY, Xu RN et al (2019) Expression of CD39 is correlated with HIV DNA levels in naive Tregs in chronically infected ART naive patients. Front Immunol 10:2465. https:\/\/doi.org\/10.3389\/fimmu.2019.02465","journal-title":"Front Immunol"},{"issue":"12","key":"9839_CR96","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/infdis\/jix547","volume":"216","author":"G Li","year":"2017","unstructured":"Li G, Nunoya JI, Cheng L, Reszka-Blanco N, Tsao LC, Jeffrey J et al (2017) Regulatory T Cells Contribute to HIV-1 Reservoir persistence in CD4 + T cells through cyclic Adenosine Monophosphate-Dependent mechanisms in Humanized mice in vivo. J Infect Dis 216(12):1579\u20131591. https:\/\/doi.org\/10.1093\/infdis\/jix547","journal-title":"J Infect Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09839-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09839-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:01:56Z","timestamp":1738728116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09839-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9839"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09839-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"2 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"894"}}